|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Income from equity method investments | |||||
| Amortization of debt costs | |||||
| Stock-based compensation | |||||
| Long-lived asset impairments | |||||
| Gain on convertible debt and debt refinancing costs | |||||
| Loss on debt refinancing | |||||
| Loss on net asset exchange for the formation of the joint ventures | |||||
| Loss (gain) on forward contracts for the issuance of convertible preferred stock | |||||
| Third-party fees associated with refinancing | |||||
| Distributions received from equity method investments | |||||
| Deferred income tax expense (benefit) | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Increase in receivables | |||||
| Decrease in inventory | |||||
| (Increase) decrease in prepaid and other current assets | |||||
| Increase (decrease) in accounts payable | |||||
| (Decrease) increase in deferred revenue and accrued liabilities | |||||
| Decrease in net lease liabilities | |||||
| Other changes in assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Refranchising proceeds, net of store acquisition costs | |||||
| Store acquisition costs | |||||
| Capital contribution to the joint ventures | |||||
| Proceeds from the assets exchange for the formation of the joint ventures | |||||
| Proceeds from the sale of Lucky Vitamin | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings under Revolving Credit Facility | |||||
| Payments on Revolving Credit Facility | |||||
| Proceeds from the issuance of convertible preferred stock | |||||
| Payments on Term Loans | |||||
| Tranche B-1 Term Loan | |||||
| Tranche B-2 Term Loan | |||||
| Total payments on Term Loans | |||||
| Proceeds from issuance of convertible senior notes | |||||
| Convertible notes repurchase | |||||
| Original issuance discount and revolving credit facility fees | |||||
| Fees associated with the issuance of convertible preferred stock | |||||
| Proceeds from exercise of stock options | |||||
| Gross excess tax benefits from stock-based compensation | |||||
| Minimum tax withholding requirements | |||||
| Cash paid for treasury stock | |||||
| Dividends paid to shareholders | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Beginning balance, cash and cash equivalents | |||||
| Ending balance, cash and cash equivalents | |||||
| Cash (received) paid during the period for: | |||||
| Income taxes | |||||
| Interest | |||||
| Non-cash investing activities: | |||||
| Capital expenditures in current liabilities | |||||
| Net assets contributed to the joint ventures | |||||
| Non-cash financing activities: | |||||
| Issuance of shares associated with exchange of convertible senior notes | |||||
| Original issuance discount | |||||
Loading...